News

Editor's Pick

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year
News Daily News

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

Author profile picture By Todd Neale
Weekend Warriors Also See Mortality Benefits With Exercise
News Daily News

Weekend Warriors Also See Mortality Benefits With Exercise

Author profile picture By Michael O'Riordan
ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)
News Conference News ACC 2025

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

Author profile picture By L.A. McKeown

Recent News

See all

Conference Coverage

See all
Sign Up for Our Newsletter

Stay up-to-date with breaking news, conference slides, and topical videos covering the spectrum of CVD.

Search All News

Filter by

Around the Web
See all
Pi-Cardia Reports First Commercial Cases with ShortCut™
First dedicated leaflet modification solution to enable TAVR in patients at risk of coronary obstruction.
Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients
Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States